Publications
Biotechnological advances on Penicillin G acylase: Pharmaceutical implications, unique expression mechanism and production strategies. Biotechnology Advances, 31, 1319-1332. 2013_biotechnological_advances_on_penicillin_g_acylase_pharmaceutical_implications_unique_expression_mechanism_and_production_strategies.pdf
. (2013). Development of an electrotransformation protocol for genetic manipulation of Clostridium pasteurianum. Biotechnology for Biofuels, 6. 2013_development_of_an_electrotransformation_protocol_for_genetic_manipulation_of_clostridium_pasteurianum.pdf
. (2013). (2013). . (2013). Developing an Extended Genomic Engineering Approach Based on Recombineering to Knock-in Heterologous Genes to Escherichia coli Genome. Molecular Biotechnology, 51, 109-118.
. (2012). Towards sustainable production of clean energy carriers from biomass resources. Applied Energy, 100, 172-186. 2012_towards_sustainable_production_of_clean_energy_carriers_from_biomass_resources.pdf
. (2012). Simultaneous clarification of Escherichia coli culture and purification of extracellularly produced penicillin G acylase using tangential flow filtration and anion-exchange membrane chromatography (TFF-AEMC). Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 900, 71-78.
(2012). (2012). Developing an RNase-free bioprocess to produce pharmaceutical-grade plasmid DNA using selective precipitation and membrane chromatography. Separation and Purification Technology, 83, 121-129.
(2011). Disulfide bond formation and its impact on the biological activity and stability of recombinant therapeutic proteins produced by Escherichia coli expression system. Biotechnology Advances, 29, 923-929. 2011_disulfide_bond_formation.pdf
. (2011). Molecular manipulation associated with disulfide bond formation to enhance the stability of recombinant therapeutic protein. Protein Expression and Purification, 75, 28-39.
. (2011). Potential application of hydrogel-based strong anion-exchange membrane for plasmid DNA purification. Journal of Chromatography B-Analytical Technologies in the Biomedical and Life Sciences, 879, 564-572.
(2011). Biochemical and genetic engineering strategies to enhance hydrogen production in photosynthetic algae and cyanobacteria. Bioresource Technology, 102, 8589-8604. 2011_biochemical_and_genetic_engineering_strategies_to_enhance_hydrogen_production_in_photosynthetic_algae_and_cyanobacteria.pdf
. (2011). Enhancing Functional Expression of Heterologous Burkholderia Lipase in Escherichia coli. Molecular Biotechnology, 47, 130-143.
. (2011). Immunosuppression Involving Soluble CD83 Induces Tolerogenic Dendritic Cells That Prevent Cardiac Allograft Rejection. Transplantation, 90, 1145-1156.
(2010). Strain improvement of Escherichia coli to enhance recombinant protein production. In Manual of Industrial Microbiology and Biotechnology (3rd ed., pp. 273-286). ASM Press. asm_mimb3_ch19.pdf
. (2010). Effect of aberrant disulfide bond formation on protein conformation and molecular property of recombinant therapeutics. Pure and Applied Chemistry, 82, 149-159.
. (2010). Structural identification of recombinant human CD83 mutant variant as a potent therapeutic protein. Protein Expression and Purification, 73, 140-146.
(2010). Enhancing functional expression of heterologous lipase B in Escherichia coli by extracellular secretion. Journal of Industrial Microbiology & Biotechnology, 37, 349-361.
. (2010). Bioprocess development for production, purification, and structural characterization of recombinant hCD83ext as a potential therapeutic protein. Protein Expression and Purification, 65, 92-99.
. (2009).